BACE1 and Alzheimer disease: As mannose is a key substrate for protein glycosylation and is involved in a variety of cell signaling and immune regulation, comprehensive restriction of mannose faces many challenges, and the development of drugs that specifically inhibit the mannose modification of BACE1 should be a new direction for AD therapeutic research.